{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:24:26Z","timestamp":1784647466112,"version":"3.55.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Saudi Pharm. J."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s44446-025-00022-6","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:32:34Z","timestamp":1749720754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emerging for non-invasive heparin delivery systems: recent advances, barriers, solutions, and applicability"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9411-4912","authenticated-orcid":false,"given":"Musa","family":"Albatsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"111851","DOI":"10.1016\/j.msec.2020.111851","volume":"121","author":"A Ahmad","year":"2021","unstructured":"Ahmad A, Vaghasiya K, Kumar A, Alam P, Raza SS, Verma RK, Khan R (2021) Enema based therapy using liposomal formulation of low molecular weight heparin for treatment of active ulcerative colitis: New adjunct therapeutic opportunity. Mater Sci Eng, C 121:111851\u2013111863. https:\/\/doi.org\/10.1016\/j.msec.2020.111851","journal-title":"Mater Sci Eng, C"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1164\/ajrccm\/145.3.566","volume":"3","author":"T Ahmed","year":"1992","unstructured":"Ahmed T, Abraham WM, D\u2019brot J (1992) Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor responses in sheep. Am Revision Respir Dis 3:566\u2013570. https:\/\/doi.org\/10.1164\/ajrccm\/145.3.566","journal-title":"Am Revision Respir Dis"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11239-022-02705-6","volume":"4","author":"A Albuloushi","year":"2022","unstructured":"Albuloushi A, Rhoten M, Kelly J, Sylvester KW, Grandoni J, Connors JM (2022) Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia. J Thromb Thrombolysis 4:597\u2013604. https:\/\/doi.org\/10.1007\/s11239-022-02705-6","journal-title":"J Thromb Thrombolysis"},{"key":"22_CR4","doi-asserted-by":"publisher","unstructured":"Al Jbour ND (2022) Enhanced oral bioavailability through nanotechnology in Saudi Arabia: a meta-analysis. Arab J Chem 4:103715\u2013103728. https:\/\/doi.org\/10.1016\/j.arabjc.2022.103715","DOI":"10.1016\/j.arabjc.2022.103715"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000528189","volume":"1","author":"J Alyoussef Alkrad","year":"2023","unstructured":"Alyoussef Alkrad J, Almalki YA, Dahmash EZ, Hassouneh LK, Neubert RH (2023) Dermal and Transdermal Macromolecule Delivery Using Enhancer Molecules and Colloidal Carrier Systems-Part 2: Percutaneous Administration of Heparin. Skin Pharmacol Physiol 1:16\u201326. https:\/\/doi.org\/10.1159\/000528189","journal-title":"Skin Pharmacol Physiol"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjh.19180","volume":"2","author":"DJ Arachchillage","year":"2024","unstructured":"Arachchillage DJ, Thachil J, Anderson JA, Baker P, Poles A, Kitchen S, Laffan M (2024) Diagnosis and management of heparin-induced thrombocytopenia. British J Hematol 2:459\u2013475. https:\/\/doi.org\/10.1111\/bjh.19180","journal-title":"British J Hematol"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1477-9560-4-6","volume":"1","author":"E Arbit","year":"2006","unstructured":"Arbit E, Goldberg M, Gomez-Orellana I, Majuru S (2006) Oral heparin: status review. Thromb J 1:6\u201313. https:\/\/doi.org\/10.1186\/1477-9560-4-6","journal-title":"Thromb J"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jps.10171","volume":"7","author":"J Arnold","year":"2002","unstructured":"Arnold J, Ahsan F, Meezan E, Pillion DJ (2002) Nasal administration of low molecular weight heparin. J Pharm Sci 7:1707\u20131714. https:\/\/doi.org\/10.1002\/jps.10171","journal-title":"J Pharm Sci"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/1061186X.2020.1795180","volume":"1","author":"MS Arshad","year":"2021","unstructured":"Arshad MS, Zafar S, Zahra AT, Zaman MH, Akhtar A, Kucuk I, Farhan M, Chang MW, Ahmad Z (2021) Fabrication and characterization of self-applicating heparin sodium microneedle patches. J Drug Target 1:60\u201368. https:\/\/doi.org\/10.1080\/1061186X.2020.1795180","journal-title":"J Drug Target"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"13326","DOI":"10.1038\/s41598-023-40489-8","volume":"1","author":"R Ashmawy","year":"2023","unstructured":"Ashmawy R, Zaki A, Baess A, El Sayed I (2023) Efficacy and safety of inhaled heparin in asthmatic and chronic obstructive pulmonary disease patients: a systematic review and a meta-analysis. Sci Rep 1:13326\u201313339. https:\/\/doi.org\/10.1038\/s41598-023-40489-8","journal-title":"Sci Rep"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"104027","DOI":"10.1016\/j.mvr.2020.104027","volume":"131","author":"S Aslani","year":"2020","unstructured":"Aslani S, Kabiri M, HosseinZadeh S, Hanaee-Ahvaz H, Taherzadeh ES, Soleimani M (2020) The applications of heparin in vascular tissue engineering. Microvasc Res 131:104027\u2013104032. https:\/\/doi.org\/10.1016\/j.mvr.2020.104027","journal-title":"Microvasc Res"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1016\/j.biomaterials.2008.04.035","volume":"23","author":"KH Bae","year":"2008","unstructured":"Bae KH, Mok H, Park TG (2008) Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death. Biomaterials 23:3376\u20133383. https:\/\/doi.org\/10.1016\/j.biomaterials.2008.04.035","journal-title":"Biomaterials"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"8426","DOI":"10.1021\/acsami.7b14888","volume":"10","author":"S Bae","year":"2018","unstructured":"Bae S, DiBalsi MJ, Meilinger N, Zhang C, Beal E, Korneva G, Brown RO, Kornev KG, Lee JS (2018) Heparin-eluting electrospun nanofiber yarns for antithrombotic vascular sutures. ACS Appl Mater Interfaces 10:8426\u20138435. https:\/\/doi.org\/10.1021\/acsami.7b14888","journal-title":"ACS Appl Mater Interfaces"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/B978-0-12-821230-1.00005-0","volume":"3","author":"S Barik","year":"2021","unstructured":"Barik S, Sharma RK, Rath C (2021) Heparin-based nanocomposites for tissue engineering. Polysaccharide-Based Nanocomposites Gene Deliv Tissue Eng 3:81\u2013101. https:\/\/doi.org\/10.1016\/B978-0-12-821230-1.00005-0","journal-title":"Polysaccharide-Based Nanocomposites Gene Deliv Tissue Eng"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"120207","DOI":"10.1016\/j.ijpharm.2021.120207","volume":"597","author":"DDA Ba\u015faran","year":"2021","unstructured":"Ba\u015faran DDA, G\u00fcnd\u00fcz U, Tezcaner A, Keskin D (2021) Topical delivery of heparin from PLGA nanoparticles entrapped in nanofibers of sericin\/gelatin scaffolds for wound healing. Int J Pharm 597:120207\u2013120213. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120207","journal-title":"Int J Pharm"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hoc.2004.09.003","volume":"1","author":"RL Bick","year":"2005","unstructured":"Bick RL, Frenkel EP, Walenga J, Fareed J, Hoppensteadt DA (2005) Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. Hematology\/oncology Clinics 1:1\u201351. https:\/\/doi.org\/10.1016\/j.hoc.2004.09.003","journal-title":"Hematology\/oncology Clinics"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00228-022-03318-x","volume":"7","author":"J Bouget","year":"2022","unstructured":"Bouget J, Balusson F, Kerbrat S, Roy PM, Viglino D, Lacut K, Pavageau L, Oger E (2022) Clinical use of low-dose parenteral anticoagulation, incidence of major bleeding and mortality: a multi-center cohort study using the French national health data system. Eur J Clin Pharmacol 7:1137\u20131144. https:\/\/doi.org\/10.1007\/s00228-022-03318-x","journal-title":"Eur J Clin Pharmacol"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijbiomac.2020.12.043","volume":"168","author":"D Cao","year":"2021","unstructured":"Cao D, Li H, Luo Y, Feng N, Ci T (2021) Heparin modified photosensitizer-loaded liposomes for tumor treatment and alleviating metastasis in phototherapy. Int J Biol Macromol 168:526\u2013536. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.043","journal-title":"Int J Biol Macromol"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1055\/s-0042-1749395","volume":"8","author":"G Carpen\u00e8","year":"2022","unstructured":"Carpen\u00e8 G, Negrini D, Lippi G, Favaloro EJ, Montagnana M (2022) Heparin: the journey from parenteral agent to nasal delivery. Thieme 8:949\u2013954. https:\/\/doi.org\/10.1055\/s-0042-1749395","journal-title":"Thieme"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.actbio.2010.08.028","volume":"2","author":"CH Chang","year":"2011","unstructured":"Chang CH, Huang WY, Lai CH, Hsu YM, Yao YH, Chen TY, Wu JY, Peng SF, Lin YH (2011) Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori. Acta Biomater 2:593\u2013603. https:\/\/doi.org\/10.1016\/j.actbio.2010.08.028","journal-title":"Acta Biomater"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/1061186X.2014.996760","volume":"4","author":"Y Chen","year":"2015","unstructured":"Chen Y, Peng J, Han M, Omar M, Hu D, Ke X, Lu N (2015) A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis. J Drug Target 4:335\u2013346. https:\/\/doi.org\/10.3109\/1061186X.2014.996760","journal-title":"J Drug Target"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S2213-2600(20)30470-7","volume":"4","author":"B Dixon","year":"2021","unstructured":"Dixon B, Smith RJ, Campbell DJ, Moran JL, Doig GS, Rechnitzer T, MacIsaac CM, Simpson N, van Haren FM, Ghosh AN, Gupta S (2021) Nebulized heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med 4:360\u2013372. https:\/\/doi.org\/10.1016\/S2213-2600(20)30470-7","journal-title":"Lancet Respir Med"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2125.1989.tb05415.x","volume":"2","author":"M Dryjski","year":"1989","unstructured":"Dryjski M, Schneider DE, Mojaverian P, Kuo BS, Bjornsson TD (1989) Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations. Br J Clin Pharmacol 2:188\u2013192. https:\/\/doi.org\/10.1111\/j.1365-2125.1989.tb05415.x","journal-title":"Br J Clin Pharmacol"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.nantod.2022.101565","volume":"46","author":"X Du","year":"2022","unstructured":"Du X, Yang X, Zhang Y, Gao S, Liu S, Ji J, Zhai G (2022) Transdermal delivery system based on heparin-modified graphene oxide for deep transportation, tumor microenvironment regulation, and immune activation. Nano Today 46:101565\u2013101572. https:\/\/doi.org\/10.1016\/j.nantod.2022.101565","journal-title":"Nano Today"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.1959.73000290002010a","volume":"12","author":"H Engelberg","year":"1959","unstructured":"Engelberg H (1959) Buccal and sublingual administration of heparin potassium (clarin): Studies of plasma triglyceride lipolysis and heparin levels. J Am Med Assoc 12:1322\u20131325. https:\/\/doi.org\/10.1001\/jama.1959.73000290002010a","journal-title":"J Am Med Assoc"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"2314832","DOI":"10.1002\/adfm.202314832","volume":"22","author":"F Fan","year":"2024","unstructured":"Fan F, Chen XM, Lin J, Lin M, Li L, Gu Y, Chai Y, Zhang H, Chen X, Li Q (2024) Peptide-Based Organic-Inorganic Hybrid Self-Assemblies for Ultrasensitive and Visual Detection of Heparin. Adv Func Mater 22:2314832\u20132314841. https:\/\/doi.org\/10.1002\/adfm.202314832","journal-title":"Adv Func Mater"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ajps.2019.11.006","volume":"4","author":"G Fang","year":"2020","unstructured":"Fang G, Tang B (2020) Advanced delivery strategies facilitating oral absorption of heparins. Asian J Pharm Sci 4:449\u2013460. https:\/\/doi.org\/10.1016\/j.ajps.2019.11.006","journal-title":"Asian J Pharm Sci"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jddst.2018.09.004","volume":"48","author":"G Fang","year":"2018","unstructured":"Fang G, Zhou J, Qian Y, Gou J, Yang X, Tang B (2018) Development and evaluation of thermo-sensitive hydrogel system with nanocomplexes for prolonged subcutaneous delivery of enoxaparin. J Drug Deliv Sci Technol 48:118\u2013124. https:\/\/doi.org\/10.1016\/j.jddst.2018.09.004","journal-title":"J Drug Deliv Sci Technol"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/000331975800900511","volume":"5","author":"HL Fuller","year":"1958","unstructured":"Fuller HL (1958) Sublingual heparin in hyperlipemia: a preliminary report. Angiology 5:311\u2013313. https:\/\/doi.org\/10.1177\/000331975800900511","journal-title":"Angiology"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1164\/rccm.2201082","volume":"11","author":"A Gunther","year":"2003","unstructured":"Gunther A, Lubke N, Ermert M, Schermuly RT, Weissmann N, Breithecker A, Markart P, Ruppert C, Quanz K, Ermert L, Grimminger F (2003) Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med 11:1358\u20131365. https:\/\/doi.org\/10.1164\/rccm.2201082","journal-title":"Am J Respir Crit Care Med"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/07328300802158752","volume":"5","author":"Y Guo","year":"2008","unstructured":"Guo Y, Yan H (2008) Preparation and characterization of heparin-stabilized gold nanoparticles. J Carbohydr Chem 5:309\u2013319. https:\/\/doi.org\/10.1080\/07328300802158752","journal-title":"J Carbohydr Chem"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11095-022-03191-4","volume":"3","author":"HM Harris","year":"2022","unstructured":"Harris HM, Boyet KL, Liu H, Dwivedi R, Ashpole NM, Tandon R, Bidwell GL III, Cheng Z, Fassero LA, Yu CS, Pomin VH (2022) Safety and pharmacokinetics of intranasally administered heparin. Pharm Res 3:541\u2013551. https:\/\/doi.org\/10.1007\/s11095-022-03191-4","journal-title":"Pharm Res"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lab.2005.01.006","volume":"3","author":"LM Hiebert","year":"2005","unstructured":"Hiebert LM, Wice SM, Ping T (2005) Increased plasma anti-Xa activity and recovery of heparin from urine suggest absorption of orally administered unfractionated heparin in human subjects. J Lab Clin Med 3:151\u2013155. https:\/\/doi.org\/10.1016\/j.lab.2005.01.006","journal-title":"J Lab Clin Med"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/hq0701.093686","volume":"7","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol 7:1094\u20131096. https:\/\/doi.org\/10.1161\/hq0701.093686","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1081\/DDC-120014576","volume":"9","author":"V Hoffart","year":"2002","unstructured":"Hoffart V, Ubrich N, Simonin C, Babak V, Vigneron C, Hoffman M, Lecompte T, Maincent P (2002) Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics. Drug Dev Ind Pharm 9:1091\u20131099. https:\/\/doi.org\/10.1081\/DDC-120014576","journal-title":"Drug Dev Ind Pharm"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1124\/pharmrev.122.000684","volume":"2","author":"J Hogwood","year":"2023","unstructured":"Hogwood J, Mulloy B, Lever R, Gray E, Page CP (2023) Pharmacology of heparin and related drugs: An update. Pharmacol Rev 2:328\u2013379. https:\/\/doi.org\/10.1124\/pharmrev.122.000684","journal-title":"Pharmacol Rev"},{"key":"22_CR37","unstructured":"Hollingsworth SJ, Hoque K, Linnard D, Corry DG, Barker SG (2000) Delivery of low molecular weight heparin for prophylaxis against deep vein thrombosis using a novel, needle-less injection device (J-Tip).\u00a0Ann R Coll Surg Engl 6:428\u2013431. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2503472\/pdf\/annrcse01628-0066.pdf"},{"key":"22_CR38","unstructured":"Horwitz O, Johnson WT, Sayen JJ, Roberts B, Whereat AF (1993) Heparin for oral use: preliminary studies.\u00a0Trans Am Clin Climatol Assoc\u00a0104:94\u2013102. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2376635\/pdf\/tacca00084-0152.pdf"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1021\/acsbiomaterials.6b00273","volume":"11","author":"L Hou","year":"2016","unstructured":"Hou L, Udangawa WRN, Pochiraju A, Dong W, Zheng Y, Linhardt RJ, Simmons TJ (2016) Synthesis of heparin-immobilized, magnetically addressable cellulose nanofibers for biomedical applications. ACS Biomater Sci Eng 11:1905\u20131913. https:\/\/doi.org\/10.1021\/acsbiomaterials.6b00273","journal-title":"ACS Biomater Sci Eng"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/j.carres.2004.08.005","volume":"15","author":"H Huang","year":"2004","unstructured":"Huang H, Yang X (2004) Synthesis of polysaccharide-stabilized gold and silver nanoparticles: A green method. Carbohyd Res 15:2627\u20132631. https:\/\/doi.org\/10.1016\/j.carres.2004.08.005","journal-title":"Carbohyd Res"},{"key":"22_CR41","doi-asserted-by":"crossref","unstructured":"Hwang HH, Lee DY (2016) Antiangiogenic actions of heparin derivatives for cancer therapy. Macromol Res 24:767\u2013772.\nhttps:\/\/link.springer.com\/article\/10.1007\/s13233-016-4111-8#citeas:~:text=DOI-,https%3A\/\/doi.org\/10.1007\/s13233%2D016%2D4111%2D8,-Keywords","DOI":"10.1007\/s13233-016-4111-8"},{"key":"22_CR42","unstructured":"Imiela J, Nosarzewski J, G\u00f3rski A (1995) Oral heparin in the treatment of rheumatoid arthritis. Archivum Immunologiae et Therapiae Experimentalis 5\u20136:313\u2013315. https:\/\/europepmc.org\/article\/med\/8744652"},{"key":"22_CR43","unstructured":"Jamshidovich AS (2024) Specific features of the effect of the heparin. Tadqiqotlar. UZ 2:34\u201338. https:\/\/tadqiqotlar.uz\/new\/article\/view\/2016"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(76)91679-2","volume":"7996","author":"LB Jaques","year":"1976","unstructured":"Jaques LB, Mahadoo J, Kavanagh LW (1976) Intrapulmonary heparin: A new procedure for anticoagulant therapy. The Lancet 7996:1157\u20131161. https:\/\/doi.org\/10.1016\/S0140-6736(76)91679-2","journal-title":"The Lancet"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"27S","DOI":"10.1177\/0003319706297741","volume":"1S","author":"R Katzenschlager","year":"2007","unstructured":"Katzenschlager R, Ugurlouglu A, Sipos G, Bihari I, Anyova EB, Hirschl M, Maruszynski M, Noszczyk W, Rybak Z, Cencora A (2007) Efficacy and tolerability of liposomal heparin spray-gel as an add-on treatment in the management of superficial venous thrombosis. Angiology 1S:27S-35S. https:\/\/doi.org\/10.1177\/0003319706297741","journal-title":"Angiology"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2217\/nnm.09.24","volume":"4","author":"MM Kemp","year":"2009","unstructured":"Kemp MM, Kumar A, Clement D, Ajayan P, Mousa S, Linhardt RJ (2009) Hyaluronan-and heparin-reduced silver nanoparticles with antimicrobial properties. Nanomedicine 4:421\u2013429. https:\/\/doi.org\/10.2217\/nnm.09.24","journal-title":"Nanomedicine"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1021\/la048646i","volume":"26","author":"K Kim","year":"2004","unstructured":"Kim K, Kwon IC, Kim SK, Lee S, Lee DY, Byun Y (2004) Preparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugates. Langmuir 26:11726\u201311731. https:\/\/doi.org\/10.1021\/la048646i","journal-title":"Langmuir"},{"key":"22_CR48","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1166\/jnn.2013.6906","volume":"3","author":"HS Kim","year":"2013","unstructured":"Kim HS, Jun SH, Koo YK, Cho S, Park Y (2013) Green synthesis and nanotopography of heparin-reduced gold nanoparticles with enhanced anticoagulant activity. J Nanosci Nanotechnol 3:2068\u20132076. https:\/\/doi.org\/10.1166\/jnn.2013.6906","journal-title":"J Nanosci Nanotechnol"},{"key":"22_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.matlet.2016.05.108","volume":"180","author":"GV Kumar","year":"2016","unstructured":"Kumar GV, Su CH, Velusamy P (2016) Ciprofloxacin loaded genipin cross-linked chitosan\/heparin nanoparticles for drug delivery application. Mater Lett 180:119\u2013122. https:\/\/doi.org\/10.1016\/j.matlet.2016.05.108","journal-title":"Mater Lett"},{"key":"22_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.colsurfb.2009.02.021","volume":"2","author":"YC Kuo","year":"2009","unstructured":"Kuo YC, Shih KH (2009) Loading efficiency and surface conductance of heparin-modified poly (lactide-co-glycolide) nanoparticles. Colloids Surf, B 2:282\u2013287. https:\/\/doi.org\/10.1016\/j.colsurfb.2009.02.021","journal-title":"Colloids Surf, B"},{"key":"22_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/B978-0-443-27402-2.00014-0","volume":"1","author":"Z Li","year":"2025","unstructured":"Li Z, Li Z (2025) Development of the anticoagulant drug fondaparinux sodium. Med Chem Drug Dev 1:161\u2013184. https:\/\/doi.org\/10.1016\/B978-0-443-27402-2.00014-0","journal-title":"Med Chem Drug Dev"},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13233-009-0134-8","volume":"18","author":"L Li","year":"2010","unstructured":"Li L, Huh KM, Lee YK, Kim SY (2010) Design of a multifunctional heparin-based nanoparticle system for anticancer drug delivery. Macromol Res 18:153\u2013161. https:\/\/doi.org\/10.1007\/s13233-009-0134-8","journal-title":"Macromol Res"},{"key":"22_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bios.2015.06.032","volume":"74","author":"Y Li","year":"2015","unstructured":"Li Y, Sun H, Shi F, Cai N, Lu L, Su X (2015) Multi-positively charged dendrimeric nanoparticles induced fluorescence quenching of graphene quantum dots for heparin and chondroitin sulfate detection. Biosens Bioelectron 74:284\u2013290. https:\/\/doi.org\/10.1016\/j.bios.2015.06.032","journal-title":"Biosens Bioelectron"},{"key":"22_CR54","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.actbio.2013.07.031","volume":"4","author":"Y Liang","year":"2014","unstructured":"Liang Y, Kiick KL (2014) Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications. Acta Biomater 4:1588\u20131600. https:\/\/doi.org\/10.1016\/j.actbio.2013.07.031","journal-title":"Acta Biomater"},{"key":"22_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3181\/00379727-77-18767","volume":"2","author":"J Litwins","year":"1951","unstructured":"Litwins J, Vorzimer JJ, Sussman LN, Applezweig N, Etess AD (1951) Sublingual administration of heparin. Proc Soc Exp Biol Med 2:325\u2013326. https:\/\/doi.org\/10.3181\/00379727-77-18767","journal-title":"Proc Soc Exp Biol Med"},{"key":"22_CR56","doi-asserted-by":"publisher","first-page":"104065","DOI":"10.1016\/j.drudis.2024.104065","volume":"29","author":"Z Liu","year":"2024","unstructured":"Liu Z, Ye Y, Ma Y, Hu B, Zhu J (2024) Inhaled heparin: Past, present, and future. Drug Discovery Today 29:104065\u2013104074. https:\/\/doi.org\/10.1016\/j.drudis.2024.104065","journal-title":"Drug Discovery Today"},{"key":"22_CR57","unstructured":"Long L, Kost J, Mitragotri S (2000) Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm Res 9:115\u2013126. https:\/\/www.proquest.com\/openview\/1bdcce9aeff047359790505d6c9741fc\/1?cbl=37334&pq-origsite=gscholar"},{"key":"22_CR58","doi-asserted-by":"publisher","unstructured":"Ma SD, Chen YL, Feng J, Liu JJ, Zuo XW, Chen XG (2016) One-step synthesis of water-dispersible and biocompatible silicon nanoparticles for selective heparin sensing and cell imaging. Anal Chem 21:10474\u201310481. https:\/\/doi.org\/10.1021\/acs.analchem.6b02448","DOI":"10.1021\/acs.analchem.6b02448"},{"key":"22_CR59","unstructured":"Medina RP, Foto D (2004) The use of bivalirudin to prevent subacute thrombosis during drug-eluting stent implantation. J Invasive Cardiol 5:236\u2013239. https:\/\/europepmc.org\/article\/med\/15152125#impact"},{"key":"22_CR60","doi-asserted-by":"publisher","first-page":"129379","DOI":"10.1016\/j.ijbiomac.2024.129379","volume":"260","author":"MK Meher","year":"2024","unstructured":"Meher MK, Naidu G, Mishra A, Poluri KM (2024) A review on multifaceted biomedical applications of heparin nanocomposites: Progress and prospects. Int J Biol Macromol 260:129379\u2013129391. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129379","journal-title":"Int J Biol Macromol"},{"key":"22_CR61","doi-asserted-by":"publisher","first-page":"9577","DOI":"10.1021\/acsami.5b12347","volume":"15","author":"L Mei","year":"2016","unstructured":"Mei L, Liu Y, Zhang H, Zhang Z, Gao H, He Q (2016) Antitumor and anti-metastasis activities of heparin-based micelle served as both carrier and drug. ACS Appl Mater Interfaces 15:9577\u20139589. https:\/\/doi.org\/10.1021\/acsami.5b12347","journal-title":"ACS Appl Mater Interfaces"},{"key":"22_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2006.04.008","volume":"2","author":"NA Motlekar","year":"2006","unstructured":"Motlekar NA, Youan BBC (2006) The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins. J Control Release 2:91\u2013101. https:\/\/doi.org\/10.1016\/j.jconrel.2006.04.008","journal-title":"J Control Release"},{"key":"22_CR63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijpharm.2016.10.039","volume":"1\u20132","author":"S Mouftah","year":"2016","unstructured":"Mouftah S, Abdel-Mottaleb MM, Lamprecht A (2016) Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles. Int J Pharm 1\u20132:565\u2013574. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.039","journal-title":"Int J Pharm"},{"key":"22_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/ph9030037","volume":"3","author":"AR Neves","year":"2016","unstructured":"Neves AR, Correia-da-Silva M, Sousa E, Pinto M (2016) Strategies to overcome heparins\u2019 low oral bioavailability. Pharmaceuticals 3:37\u201343. https:\/\/doi.org\/10.3390\/ph9030037","journal-title":"Pharmaceuticals"},{"key":"22_CR65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000054138","volume":"5","author":"A Nissan","year":"2000","unstructured":"Nissan A, Ziv E, Kidron M, Bar-On H, Friedman G, Hyam E, Eldor A (2000) Intestinal absorption of low molecular weight heparin in animals and human subjects. Pathophysiol Haemost Thromb 5:225\u2013232. https:\/\/doi.org\/10.1159\/000054138","journal-title":"Pathophysiol Haemost Thromb"},{"key":"22_CR66","doi-asserted-by":"publisher","first-page":"1800644","DOI":"10.1002\/smll.201800644","volume":"32","author":"LC Noukeu","year":"2018","unstructured":"Noukeu LC, Wolf J, Yuan B, Banerjee S, Nguyen KT (2018) Nanoparticles for detection and treatment of peripheral arterial disease. Small 32:1800644\u20131800651. https:\/\/doi.org\/10.1002\/smll.201800644","journal-title":"Small"},{"key":"22_CR67","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-3-030-35910-2_5","volume":"3","author":"AC Ortiz","year":"2020","unstructured":"Ortiz AC, Morales JO (2020) Buccal delivery of nanoparticles. Mucosal Deliv Drugs Biol Nanoparticles 3:107\u2013124. https:\/\/doi.org\/10.1007\/978-3-030-35910-2_5","journal-title":"Mucosal Deliv Drugs Biol Nanoparticles"},{"key":"22_CR68","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jconrel.2006.05.017","volume":"3","author":"K Park","year":"2006","unstructured":"Park K, Lee GY, Kim YS, Yu M, Park RW, Kim IS, Kim SY, Byun Y (2006) Heparin\u2013deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J Control Release 3:300\u2013306. https:\/\/doi.org\/10.1016\/j.jconrel.2006.05.017","journal-title":"J Control Release"},{"key":"22_CR69","doi-asserted-by":"publisher","first-page":"125873","DOI":"10.1016\/j.talanta.2024.125873","volume":"3","author":"A Pathak","year":"2024","unstructured":"Pathak A, Verma N, Tripathi S, Mishra A, Poluri KM (2024) Nanosensor based approaches for quantitative detection of heparin. Talanta 3:125873\u2013212582. https:\/\/doi.org\/10.1016\/j.talanta.2024.125873","journal-title":"Talanta"},{"key":"22_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.snb.2015.02.070","volume":"213","author":"X Peng","year":"2015","unstructured":"Peng X, Long Q, Li H, Zhang Y, Yao S (2015) \u201cTurn on-off\u201d fluorescent sensor for protamine and heparin based on label-free silicon quantum dots coupled with gold nanoparticles. Sens Actuators, B Chem 213:131\u2013138. https:\/\/doi.org\/10.1016\/j.snb.2015.02.070","journal-title":"Sens Actuators, B Chem"},{"key":"22_CR71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/pharmaceutics11070317","volume":"7","author":"I Pilipenko","year":"2019","unstructured":"Pilipenko I, Korzhikov-Vlakh V, Sharoyko V, Zhang N, Sch\u00e4fer-Korting M, R\u00fchl E, Zoschke C, Tennikova T (2019) pH-sensitive chitosan\u2013heparin nanoparticles for effective delivery of genetic drugs into epithelial cells. Pharmaceutics 7:317\u2013333. https:\/\/doi.org\/10.3390\/pharmaceutics11070317","journal-title":"Pharmaceutics"},{"key":"22_CR72","doi-asserted-by":"publisher","first-page":"9867","DOI":"10.1073\/pnas.0402891101","volume":"26","author":"Y Qi","year":"2004","unstructured":"Qi Y, Zhao G, Liu D, Shriver Z, Sundaram M, Sengupta S, Venkataraman G, Langer R, Sasisekharan R (2004) Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. Proc Natl Acad Sci 26:9867\u20139872. https:\/\/doi.org\/10.1073\/pnas.0402891101","journal-title":"Proc Natl Acad Sci"},{"key":"22_CR73","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3390\/pharmaceutics14102210","volume":"10","author":"R Rathi","year":"2022","unstructured":"Rathi R, Sanshita Kumar A, Vishvakarma V, Huanbutta K, Singh I, Sangnim T (2022) Advancements in rectal drug delivery systems: clinical trials, and patents perspective. Pharmaceutics 10:2210\u20132247. https:\/\/doi.org\/10.3390\/pharmaceutics14102210","journal-title":"Pharmaceutics"},{"key":"22_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13404-013-0107-8","volume":"47","author":"MDP Rodr\u00edguez-Torres","year":"2014","unstructured":"Rodr\u00edguez-Torres MDP, D\u00edaz-Torres LA, Salas P, Rodr\u00edguez-Gonz\u00e1lez C, Olmos-L\u00f3pez M (2014) UV photochemical synthesis of heparin-coated gold nanoparticles. Gold Bulletin 47:21\u201331. https:\/\/doi.org\/10.1007\/s13404-013-0107-8","journal-title":"Gold Bulletin"},{"key":"22_CR75","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1155\/2018\/9780489","volume":"1","author":"MDP Rodriguez-Torres","year":"2018","unstructured":"Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA (2018) Heparin-based nanoparticles: An overview of their applications. J Nanomater 1:489\u2013497. https:\/\/doi.org\/10.1155\/2018\/9780489","journal-title":"J Nanomater"},{"key":"22_CR76","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1389201015666140915151649","volume":"7","author":"A Schluter","year":"2014","unstructured":"Schluter A, Lamprecht A (2014) Current developments for the oral delivery of heparin. Curr Pharm Biotechnol 7:640\u2013649. https:\/\/doi.org\/10.2174\/1389201015666140915151649","journal-title":"Curr Pharm Biotechnol"},{"key":"22_CR77","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2023.7843","volume":"22","author":"D Schrag","year":"2023","unstructured":"Schrag D, Uno H, Rosovsky R, Rutherford C, Sanfilippo K, Villano JL, Drescher M, Jayaram N, Holmes C, Feldman L, Zattra O (2023) Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial. Jama 22:1924\u20131933. https:\/\/doi.org\/10.1001\/jama.2023.7843","journal-title":"Jama"},{"key":"22_CR78","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/acsbiomaterials.6b00495","volume":"12","author":"FP Seib","year":"2016","unstructured":"Seib FP, Tsurkan M, Freudenberg U, Kaplan DL, Werner C (2016) Heparin-modified polyethylene glycol microparticle aggregates for focal cancer chemotherapy. ACS Biomater Sci Eng 12:2287\u20132293. https:\/\/doi.org\/10.1021\/acsbiomaterials.6b00495","journal-title":"ACS Biomater Sci Eng"},{"key":"22_CR79","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389201013378734","volume":"2","author":"S Senel","year":"2001","unstructured":"Senel S, Kremer M, Katalin N, Squier C (2001) Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharm Biotechnol 2:175\u2013186. https:\/\/doi.org\/10.2174\/1389201013378734","journal-title":"Curr Pharm Biotechnol"},{"key":"22_CR80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/000331975901000301","volume":"3","author":"HE Shaftel","year":"1959","unstructured":"Shaftel HE, Selman D (1959) The effect of sublingual heparin on hyperlipemic serum. Angiology 3:131\u2013133. https:\/\/doi.org\/10.1177\/000331975901000301","journal-title":"Angiology"},{"key":"22_CR81","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3109\/03639045.2012.736518","volume":"11","author":"MA Shahbazi","year":"2013","unstructured":"Shahbazi MA, Hamidi M (2013) The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release. Drug Dev Ind Pharm 11:1774\u20131782. https:\/\/doi.org\/10.3109\/03639045.2012.736518","journal-title":"Drug Dev Ind Pharm"},{"key":"22_CR82","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/jphp.12076","volume":"8","author":"MA Shahbazi","year":"2013","unstructured":"Shahbazi MA, Hamidi M, Mohammadi-Samani S (2013) Preparation, optimization, and in-vitro\/in-vivo\/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation. J Pharm Pharmacol 8:1118\u20131133. https:\/\/doi.org\/10.1111\/jphp.12076","journal-title":"J Pharm Pharmacol"},{"key":"22_CR83","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.2174\/1381612827666210820100723","volume":"42","author":"M Sharma","year":"2021","unstructured":"Sharma M, Waghela S, Mhatre R, Saraogi GK (2021) A recent update on intranasal delivery of high molecular weight proteins, peptides, and hormones. Curr Pharm des 42:4279\u20134299. https:\/\/doi.org\/10.2174\/1381612827666210820100723","journal-title":"Curr Pharm des"},{"key":"22_CR84","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/ph16040584","volume":"4","author":"JK Shute","year":"2023","unstructured":"Shute JK (2023) Heparin, low molecular weight heparin, and non-anticoagulant derivatives for the treatment of inflammatory lung disease. Pharmaceuticals 4:584\u2013610. https:\/\/doi.org\/10.3390\/ph16040584","journal-title":"Pharmaceuticals"},{"key":"22_CR85","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ijpharm.2018.07.008","volume":"1","author":"I Sibum","year":"2018","unstructured":"Sibum I, Hagedoorn P, de Boer AH, Frijlink HW, Grasmeijer F (2018) Challenges for pulmonary delivery of high powder doses. Int J Pharm 1:325\u2013336. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.008","journal-title":"Int J Pharm"},{"key":"22_CR86","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/02652048.2010.507880","volume":"3","author":"YK Song","year":"2011","unstructured":"Song YK, Hyun SY, Kim HT, Kim CK, Oh JM (2011) Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes. J Microencapsul 3:151\u2013158. https:\/\/doi.org\/10.3109\/02652048.2010.507880","journal-title":"J Microencapsul"},{"key":"22_CR87","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1212\/WNL.15.5.486","volume":"5","author":"EV Spudis","year":"1965","unstructured":"Spudis EV, Hutaff LW, Miller HS, Lofland H, with the technical assistance of Mrs. Marcia Isaacs (1965) Sublingual heparin: The inability to detect lipid-clearing or anticoagulant effects of high doses. Neurology 5:486\u2013486. https:\/\/doi.org\/10.1212\/WNL.15.5.486","journal-title":"Neurology"},{"key":"22_CR88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.22159\/ajpcr.2017.v10i10.20138","volume":"10","author":"G Srikanth","year":"2017","unstructured":"Srikanth G, Kamath AT, Chhaparwal Y, Dhara V, Singh A (2017) Heparin induced sublingual hematoma: A rare oral complication. Asian J Pharm Clin Res 10:19\u201320. https:\/\/doi.org\/10.22159\/ajpcr.2017.v10i10.20138","journal-title":"Asian J Pharm Clin Res"},{"key":"22_CR89","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.2042-7158.1981.tb13931.x","volume":"1","author":"L Stanzani","year":"1981","unstructured":"Stanzani L, Mascellani G, Corbelli GP, Bianchini P (1981) Rectal absorption of some glycosaminoglycan sulphates and heparin in rats. J Pharm Pharmacol 1:783\u2013786. https:\/\/doi.org\/10.1111\/j.2042-7158.1981.tb13931.x","journal-title":"J Pharm Pharmacol"},{"key":"22_CR90","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/pharmaceutics12070607","volume":"7","author":"B Tang","year":"2020","unstructured":"Tang B, Qian Y, Fang G (2020) Development of lipid\u2013polymer hybrid nanoparticles for improving oral absorption of enoxaparin. Pharmaceutics 7:607\u2013618. https:\/\/doi.org\/10.3390\/pharmaceutics12070607","journal-title":"Pharmaceutics"},{"key":"22_CR91","doi-asserted-by":"publisher","first-page":"120002","DOI":"10.1016\/j.carbpol.2022.120002","volume":"297","author":"B Tang","year":"2022","unstructured":"Tang B, Yang X, Zhang A, Wang Q, Fan L, Fang G (2022) Polypseudorotaxane hydrogel based on Tween 80 and \u03b1-cyclodextrin for sustained delivery of low molecular weight heparin. Carbohyd Polym 297:120002\u2013120011. https:\/\/doi.org\/10.1016\/j.carbpol.2022.120002","journal-title":"Carbohyd Polym"},{"key":"22_CR92","doi-asserted-by":"crossref","unstructured":"Thi HN, Ngoc SN, Minh TV, Le Van Q, Bui VTD, Nguyen NH (2024) A heparin-based nanogel system for redox and pH dual-responsive delivery of cisplatin. Biomed Mater 2:025012\u2013025023. https:\/\/iopscience.iop.org\/article\/10.1088\/1748-605X\/ad1dfb\/meta#:~:text=10.1088\/1748%2D605X\/ad1dfb","DOI":"10.1088\/1748-605X\/ad1dfb"},{"key":"22_CR93","unstructured":"Uryvaev IV, Iudel'son IB, Sergeev VV (1997) Changes in hemostasis and vagal tonus in healthy individuals and patients with facial neuropathy by micro-dose heparin stimulation of nasal receptors. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 8:22\u201323. https:\/\/europepmc.org\/article\/MED\/9340043"},{"key":"22_CR94","doi-asserted-by":"publisher","first-page":"100191","DOI":"10.1016\/j.ijpx.2023.100191","volume":"6","author":"TS van Solinge","year":"2023","unstructured":"van Solinge TS, Friis KP, O\u2019Brien K, Verschoor RL, van Aarle J, Koekman A, Breakefield XO, Vader P, Schiffelers R, Broekman M (2023) Heparin interferes with the uptake of liposomes in glioma. Int J Pharm 6:100191\u2013100201. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100191","journal-title":"Int J Pharm"},{"key":"22_CR95","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1023\/A:1012161313701","volume":"14","author":"R Vanbever","year":"1997","unstructured":"Vanbever R, Prausnitz MR, Pr\u00e9at V (1997) Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res 14:638\u2013644. https:\/\/doi.org\/10.1023\/A:1012161313701","journal-title":"Pharm Res"},{"key":"22_CR96","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1067\/mai.2001.118785","volume":"5","author":"C Vancheri","year":"2001","unstructured":"Vancheri C, Mastruzzo C, Armato F, Tomaselli V, Magr\u00ec S, Pistorio MP, LaMicela M, D\u2019Amico L, Crimi N (2001) Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis. J Allergy Clin Immunol 5:703\u2013708. https:\/\/doi.org\/10.1067\/mai.2001.118785","journal-title":"J Allergy Clin Immunol"},{"key":"22_CR97","doi-asserted-by":"publisher","first-page":"13463","DOI":"10.3390\/ijms140713463","volume":"7","author":"E Vismara","year":"2013","unstructured":"Vismara E, Valerio A, Coletti A, Torri G, Bertini S, Eisele G, Gornati R, Bernardini G (2013) Non-covalent synthesis of metal oxide nanoparticle\u2013heparin hybrid systems: A new approach to bioactive nanoparticles. Int J Mol Sci 7:13463\u201313481. https:\/\/doi.org\/10.3390\/ijms140713463","journal-title":"Int J Mol Sci"},{"key":"22_CR98","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4155\/tde-2020-0024","volume":"2","author":"D Vora","year":"2021","unstructured":"Vora D, Kim Y, Banga AK (2021) Development and evaluation of a heparin gel for transdermal delivery via laser-generated micropores. Ther Deliv 2:133\u2013144. https:\/\/doi.org\/10.4155\/tde-2020-0024","journal-title":"Ther Deliv"},{"key":"22_CR99","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1254\/jjp.82.326","volume":"4","author":"QL Wang","year":"2000","unstructured":"Wang QL, Shang XY, Zhang SL, Ji JB, Cheng YN, Meng YJ, Zhu YJ (2000) Effects of inhaled low molecular weight heparin on airway allergic inflammation in aerosol-ovalbumin-sensitized guinea pigs. Japanese J Pharmacol 4:326\u2013330. https:\/\/doi.org\/10.1254\/jjp.82.326","journal-title":"Japanese J Pharmacol"},{"key":"22_CR100","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1006\/bbrc.1997.6701","volume":"3","author":"JC Weaver","year":"1997","unstructured":"Weaver JC, Vanbever R, Vaughan TE, Prausnitz MR (1997) Heparin alters transdermal transport associated with electroporation. Biochem Biophys Res Commun 3:637\u2013640. https:\/\/doi.org\/10.1006\/bbrc.1997.6701","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR101","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/0002-9343(64)90197-4","volume":"37","author":"E Windsor","year":"1964","unstructured":"Windsor E, Freeman L (1964) An investigation of routes of administration of heparin other than injection. Am J Med 37:408\u2013416. https:\/\/doi.org\/10.1016\/0002-9343(64)90197-4","journal-title":"Am J Med"},{"key":"22_CR102","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0029-7844(95)00040-X","volume":"5","author":"AG Witlin","year":"1995","unstructured":"Witlin AG, Sibai BM (1995) Postpartum ovarian vein thrombosis after vaginal delivery: a report of 11 cases. Obstet Gynecol 5:775\u2013780. https:\/\/doi.org\/10.1016\/0029-7844(95)00040-X","journal-title":"Obstet Gynecol"},{"key":"22_CR103","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.biomaterials.2014.11.005","volume":"39","author":"W Wu","year":"2015","unstructured":"Wu W, Yao W, Wang X, Xie C, Zhang J, Jiang X (2015) Bioreducible heparin-based nanogel drug delivery system. Biomaterials 39:260\u2013268. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.11.005","journal-title":"Biomaterials"},{"key":"22_CR104","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/adfm.200500879","volume":"13","author":"SC Wuang","year":"2006","unstructured":"Wuang SC, Neoh KG, Kang ET, Pack DW, Leckband DE (2006) Heparinized magnetic nanoparticles: in-vitro assessment for biomedical applications. Adv Func Mater 13:1723\u20131730. https:\/\/doi.org\/10.1002\/adfm.200500879","journal-title":"Adv Func Mater"},{"key":"22_CR105","doi-asserted-by":"publisher","first-page":"116660","DOI":"10.1016\/j.carbpol.2020.116660","volume":"246","author":"Y Yan","year":"2020","unstructured":"Yan Y, Sun Y, Wang P, Zhang R, Huo C, Gao T, Song C, Xing J, Dong Y (2020) Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis. Carbohyd Polym 246:116660\u2013116669. https:\/\/doi.org\/10.1016\/j.carbpol.2020.116660","journal-title":"Carbohyd Polym"},{"key":"22_CR106","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10856-013-5111-2","volume":"25","author":"Y Yang","year":"2014","unstructured":"Yang Y, Tang H, K\u00f6witsch A, M\u00e4der K, Hause G, Ulrich J, Groth T (2014) Novel mineralized heparin\u2013gelatin nanoparticles for potential application in tissue engineering of bone. J Mater Sci - Mater Med 25:669\u2013680. https:\/\/doi.org\/10.1007\/s10856-013-5111-2","journal-title":"J Mater Sci - Mater Med"},{"key":"22_CR107","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.carbpol.2015.09.023","volume":"136","author":"YC Yang","year":"2016","unstructured":"Yang YC, Cai J, Yin J, Zhang J, Wang KL, Zhang ZT (2016) Heparin-functionalized Pluronic nanoparticles to enhance the antitumor efficacy of sorafenib in gastric cancers. Carbohyd Polym 136:782\u2013790. https:\/\/doi.org\/10.1016\/j.carbpol.2015.09.023","journal-title":"Carbohyd Polym"},{"key":"22_CR108","doi-asserted-by":"publisher","first-page":"119793","DOI":"10.1016\/j.carbpol.2022.119793","volume":"294","author":"X Yang","year":"2022","unstructured":"Yang X, Wang Q, Zhang A, Shao X, Liu T, Tang B, Fang G (2022) Strategies for sustained release of heparin: A review. Carbohyd Polym 294:119793\u2013119802. https:\/\/doi.org\/10.1016\/j.carbpol.2022.119793","journal-title":"Carbohyd Polym"},{"key":"22_CR109","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/jamp.2015.1273","volume":"3","author":"A Yildiz-Pekoz","year":"2017","unstructured":"Yildiz-Pekoz A, Ozsoy Y (2017) Inhaled heparin: therapeutic efficacy and recent formulations. J Aerosol Med Pulm Drug Deliv 3:143\u2013156. https:\/\/doi.org\/10.1089\/jamp.2015.1273","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"22_CR110","doi-asserted-by":"publisher","unstructured":"Yu Y, Dai M, Li M, Song G, Yin Y, Wang J (2025) Bioabsorbable stent-covering with sustained anticoagulant activity fabricated via alternate layer-by-layer self-assembly of heparin and silk fibroin. ACS Appl Mater Interfaces 2:163\u2013174. https:\/\/doi.org\/10.1021\/acsami.4c16643","DOI":"10.1021\/acsami.4c16643"},{"key":"22_CR111","doi-asserted-by":"publisher","unstructured":"Yuk SH, Oh KS, Cho SH, Lee BS, Kim SY, Kwak BK, Kim K, Kwon IC (2011) Glycol chitosan\/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging. Biomacromolecules 6:2335\u20132343. https:\/\/doi.org\/10.1021\/bm200413a","DOI":"10.1021\/bm200413a"},{"key":"22_CR112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.36721\/PJPS.2021.34.3.SUP.1165-1170.1","volume":"5","author":"S Zafar","year":"2021","unstructured":"Zafar S, Hassan S, Mudassir J, Hussain A, Abbas N, Latif S, Ali E, Arshad MS (2021) Microneedle based transcutaneous delivery of low molecular weight heparin. Pakistan J Pharm Sci 5:34\u201341. https:\/\/doi.org\/10.36721\/PJPS.2021.34.3.SUP.1165-1170.1","journal-title":"Pakistan J Pharm Sci"},{"key":"22_CR113","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bioactmat.2023.08.002","volume":"31","author":"EN Zare","year":"2024","unstructured":"Zare EN, Khorsandi D, Zarepour A, Yilmaz H, Agarwal T, Hooshmand S, Mohammadinejad R, Ozdemir F, Sahin O, Adiguzel S, Khan H (2024) Biomedical applications of engineered heparin-based materials. Bioactive Mater 31:87\u2013118. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.08.002","journal-title":"Bioactive Mater"},{"key":"22_CR114","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1039\/d1bm00703c","volume":"16","author":"H Zhai","year":"2021","unstructured":"Zhai H, Zhang C, Ou H, Chen M (2021) Transdermal delivery of heparin using low-frequency sonophoresis in combination with sponge spicules for venous thrombosis treatment. Biomater Sci 16:5612\u20135625. https:\/\/doi.org\/10.1039\/d1bm00703c","journal-title":"Biomater Sci"},{"key":"22_CR115","doi-asserted-by":"publisher","first-page":"145101","DOI":"10.1088\/0957-4484\/26\/14\/145101","volume":"14","author":"T Zhang","year":"2015","unstructured":"Zhang T, Xiong H, Dahmani FZ, Sun L, Li Y, Yao L, Zhou J, Yao J (2015) Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles. Nanotechnology 14:145101\u2013145120. https:\/\/doi.org\/10.1088\/0957-4484\/26\/14\/145101","journal-title":"Nanotechnology"},{"key":"22_CR116","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijpharm.2016.07.020","volume":"1","author":"F Zhang","year":"2016","unstructured":"Zhang F, Fei J, Sun M, Ping Q (2016) Heparin modification enhances the delivery and tumor targeting of paclitaxel-loaded N-octyl-N-trimethyl chitosan micelles. Int J Pharm 1:390\u2013402. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.020","journal-title":"Int J Pharm"},{"key":"22_CR117","doi-asserted-by":"publisher","first-page":"122797","DOI":"10.1016\/j.carbpol.2024.122797","volume":"348","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang SY, Zhang YT, Ren Q (2025) Characterization of the mechanisms governing heparin-bovine serum albumin complex interactions and associated anticoagulant activity. Carbohyd Polym 348:122797\u2013122808. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122797","journal-title":"Carbohyd Polym"},{"key":"22_CR118","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5603\/ARM.2019.0029","volume":"3","author":"M Zieli\u0144ski","year":"2019","unstructured":"Zieli\u0144ski M, Wr\u00f3blewski P, Kozielski J (2019) Is inhaled heparin a viable therapeutic option in inhalation injury? Adv Respiratory Med 3:184\u2013188. https:\/\/doi.org\/10.5603\/ARM.2019.0029","journal-title":"Adv Respiratory Med"},{"key":"22_CR119","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0006-2952(83)90575-0","volume":"5","author":"E Ziv","year":"1983","unstructured":"Ziv E, Eldor A, Kleinman Y, Bar-On H, Kidron M (1983) Bile salts facilitate the absorption of heparin from the intestine. Biochem Pharmacol 5:773\u2013776. https:\/\/doi.org\/10.1016\/0006-2952(83)90575-0","journal-title":"Biochem Pharmacol"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-025-00022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44446-025-00022-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44446-025-00022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T14:24:09Z","timestamp":1754403849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44446-025-00022-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s44446-025-00022-6","relation":{},"ISSN":["1319-0164","2213-7475"],"issn-type":[{"value":"1319-0164","type":"print"},{"value":"2213-7475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by the author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The author confirms that there is no conflict of interest related to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}